vs

Side-by-side financial comparison of Organogenesis Holdings Inc. (ORGO) and Whitestone REIT (WSR). Click either name above to swap in a different company.

Whitestone REIT is the larger business by last-quarter revenue ($43.9M vs $37.2M, roughly 1.2× Organogenesis Holdings Inc.). On growth, Whitestone REIT posted the faster year-over-year revenue change (7.5% vs -57.1%). Over the past eight quarters, Whitestone REIT's revenue compounded faster (8.7% CAGR vs -46.5%).

Organogenesis Holdings Inc. is a leading regenerative medicine firm specializing in developing and manufacturing advanced therapeutic products for wound care, surgical repair, sports medicine, and dermatology. It serves healthcare providers and patients primarily in the U.S. and select international markets, offering clinically validated solutions for unmet medical needs.

Whitestone REIT is a publicly traded real estate investment trust that acquires, owns, manages and redevelops open-air community shopping centers, primarily located in high-growth metropolitan areas across the southwestern and southeastern United States. Its property portfolio is largely anchored by daily necessity, service-focused retail tenants that cater to regular local consumer demand.

ORGO vs WSR — Head-to-Head

Bigger by revenue
WSR
WSR
1.2× larger
WSR
$43.9M
$37.2M
ORGO
Growing faster (revenue YoY)
WSR
WSR
+64.6% gap
WSR
7.5%
-57.1%
ORGO
Faster 2-yr revenue CAGR
WSR
WSR
Annualised
WSR
8.7%
-46.5%
ORGO

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
ORGO
ORGO
WSR
WSR
Revenue
$37.2M
$43.9M
Net Profit
$22.8M
Gross Margin
30.8%
Operating Margin
-185.1%
53.0%
Net Margin
52.0%
Revenue YoY
-57.1%
7.5%
Net Profit YoY
31.7%
EPS (diluted)
$0.43

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ORGO
ORGO
WSR
WSR
Q1 26
$37.2M
Q4 25
$225.6M
$43.9M
Q3 25
$150.9M
$41.0M
Q2 25
$101.0M
$37.9M
Q1 25
$86.7M
$38.0M
Q4 24
$126.7M
$40.8M
Q3 24
$115.2M
$38.6M
Q2 24
$130.2M
$37.6M
Net Profit
ORGO
ORGO
WSR
WSR
Q1 26
Q4 25
$43.7M
$22.8M
Q3 25
$21.6M
$18.3M
Q2 25
$-9.4M
$5.1M
Q1 25
$-18.8M
$3.7M
Q4 24
$7.7M
$17.3M
Q3 24
$12.3M
$7.6M
Q2 24
$-17.0M
$2.6M
Gross Margin
ORGO
ORGO
WSR
WSR
Q1 26
30.8%
Q4 25
Q3 25
Q2 25
Q1 25
72.6%
Q4 24
75.5%
Q3 24
76.7%
Q2 24
77.6%
Operating Margin
ORGO
ORGO
WSR
WSR
Q1 26
-185.1%
Q4 25
28.1%
53.0%
Q3 25
13.7%
45.5%
Q2 25
-12.5%
13.8%
Q1 25
-30.9%
10.2%
Q4 24
8.1%
43.3%
Q3 24
5.4%
20.3%
Q2 24
-10.7%
7.2%
Net Margin
ORGO
ORGO
WSR
WSR
Q1 26
Q4 25
19.4%
52.0%
Q3 25
14.3%
44.7%
Q2 25
-9.3%
13.3%
Q1 25
-21.7%
9.7%
Q4 24
6.1%
42.5%
Q3 24
10.7%
19.7%
Q2 24
-13.1%
6.9%
EPS (diluted)
ORGO
ORGO
WSR
WSR
Q1 26
Q4 25
$0.31
$0.43
Q3 25
$0.11
$0.35
Q2 25
$-0.10
$0.10
Q1 25
$-0.17
$0.07
Q4 24
$0.05
$0.34
Q3 24
$0.09
$0.15
Q2 24
$-0.13
$0.05

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ORGO
ORGO
WSR
WSR
Cash + ST InvestmentsLiquidity on hand
$91.4M
$4.9M
Total DebtLower is stronger
$649.4M
Stockholders' EquityBook value
$458.1M
Total Assets
$520.0M
$1.2B
Debt / EquityLower = less leverage
1.42×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ORGO
ORGO
WSR
WSR
Q1 26
$91.4M
Q4 25
$93.7M
$4.9M
Q3 25
$63.7M
$6.8M
Q2 25
$73.1M
$5.3M
Q1 25
$110.0M
$5.6M
Q4 24
$135.6M
$5.2M
Q3 24
$94.3M
$2.5M
Q2 24
$89.9M
$3.2M
Total Debt
ORGO
ORGO
WSR
WSR
Q1 26
Q4 25
$649.4M
Q3 25
Q2 25
Q1 25
Q4 24
$632.5M
Q3 24
$62.3M
Q2 24
$63.8M
Stockholders' Equity
ORGO
ORGO
WSR
WSR
Q1 26
Q4 25
$300.1M
$458.1M
Q3 25
$255.1M
$439.5M
Q2 25
$233.2M
$427.5M
Q1 25
$242.9M
$431.0M
Q4 24
$262.9M
$438.2M
Q3 24
$278.5M
$419.5M
Q2 24
$263.5M
$418.3M
Total Assets
ORGO
ORGO
WSR
WSR
Q1 26
$520.0M
Q4 25
$598.7M
$1.2B
Q3 25
$509.8M
$1.1B
Q2 25
$461.1M
$1.2B
Q1 25
$467.4M
$1.1B
Q4 24
$497.9M
$1.1B
Q3 24
$446.3M
$1.1B
Q2 24
$443.2M
$1.1B
Debt / Equity
ORGO
ORGO
WSR
WSR
Q1 26
Q4 25
1.42×
Q3 25
Q2 25
Q1 25
Q4 24
1.44×
Q3 24
0.22×
Q2 24
0.24×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ORGO
ORGO
WSR
WSR
Operating Cash FlowLast quarter
$50.8M
Free Cash FlowOCF − Capex
$50.5M
FCF MarginFCF / Revenue
114.9%
Capex IntensityCapex / Revenue
0.7%
Cash ConversionOCF / Net Profit
2.22×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ORGO
ORGO
WSR
WSR
Q1 26
Q4 25
$39.4M
$50.8M
Q3 25
$3.1M
$18.0M
Q2 25
$-32.9M
$13.8M
Q1 25
$-19.9M
$3.1M
Q4 24
$10.9M
$58.2M
Q3 24
$8.7M
$16.4M
Q2 24
$4.7M
$12.3M
Free Cash Flow
ORGO
ORGO
WSR
WSR
Q1 26
Q4 25
$34.8M
$50.5M
Q3 25
$844.0K
Q2 25
$-36.5M
Q1 25
$-23.6M
Q4 24
$7.6M
$58.0M
Q3 24
$6.1M
Q2 24
$2.9M
FCF Margin
ORGO
ORGO
WSR
WSR
Q1 26
Q4 25
15.4%
114.9%
Q3 25
0.6%
Q2 25
-36.1%
Q1 25
-27.2%
Q4 24
6.0%
142.1%
Q3 24
5.3%
Q2 24
2.2%
Capex Intensity
ORGO
ORGO
WSR
WSR
Q1 26
Q4 25
2.1%
0.7%
Q3 25
1.5%
Q2 25
3.6%
Q1 25
4.2%
Q4 24
2.7%
0.5%
Q3 24
2.2%
Q2 24
1.4%
Cash Conversion
ORGO
ORGO
WSR
WSR
Q1 26
Q4 25
0.90×
2.22×
Q3 25
0.14×
0.98×
Q2 25
2.74×
Q1 25
0.83×
Q4 24
1.43×
3.36×
Q3 24
0.71×
2.15×
Q2 24
4.73×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons